Bio Green Med Solution, Inc. (BGMS) — Institutional Holders, Q2 2026

7 institutional investment managers reported a BGMS position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $93.1K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

BGMS in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

1

Added to

4

Trimmed

0

Sold out

3

Biggest buyers

  1. CITADEL ADVISORSAdded · +53,189 sh+$48.4K
  2. JANE STREET GROUPNew · +16,291 sh+$14.8K
  3. UBS Group AGAdded · +2,163 sh+$2.0K
  4. Tower Research Capital (TRC)Added · +1,461 sh+$1.3K
  5. SBI Securities , Ltd.Added · +201 sh+$183.00

Biggest sellers

  1. RENAISSANCE TECHNOLOGIESSold out · -46,100 sh-$42.0K
  2. XTX Topco LtdSold out · -21,872 sh-$19.9K
  3. GEODE CAPITAL MANAGEMENTSold out · -21,588 sh-$19.6K

BGMS 13F holders ranked 1–7 of 7

Institutional investors reporting a position in Bio Green Med Solution, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
CITADEL ADVISORS#1 · 75,240 sh$68.5K+241.2%
JANE STREET GROUP#2 · 16,291 sh$14.8KNew
Tower Research Capital (TRC)#3 · 5,722 sh$5.2K+34.3%
UBS Group AG#4 · 4,332 sh$3.9K+99.7%
SBI Securities , Ltd.#5 · 701 sh$638.00+40.2%
Archer Investment#6 · 1 sh$1.000.0%
OSAIC#7 · 1 sh$0.000.0%

Funds that sold out of BGMS in Q2 2026 (3)

Held BGMS at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held BGMS in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
RENAISSANCE TECHNOLOGIES46,100 sh$46.1K
XTX Topco Ltd21,872 sh$21.9K
GEODE CAPITAL MANAGEMENT21,588 sh$21.6K

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.